Global Poisoning Treatment Market

Poisoning Treatment Comprehensive Study by Application (Hospital, Emergency Center, Others), Treatment Type (Antidote, Gastric Lavage, Enema, Hemodialysis, Others), Agents of Poisoning (Sedatives, Pesticides, Chemicals, Overdose of Drugs, Alcohol, Others) Players and Region - Global Market Outlook to 2024

Poisoning Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Poisoning Treatment Market Overview:
Poisoning is an interaction with a substance that results in toxicity. Symptoms differ, but certain common syndromes may suggest specific classes of poisons. Diagnosis is mainly clinical, but for some poisonings, blood and urine tests can help. Treatment is helpful for most poisonings; specific antidotes are essential for a few. Prevention comprises labeling drug containers clearly and keeping poisons out of the reach of children. Seriously poisoned patients may need assisted ventilation or treatment of cardiovascular collapse. Patients with impaired consciousness may require continual monitoring or restraints. Some of the key players profiled in the study are Cumberland Pharmaceuticals (United States), Pfizer (United States), BTG PLC (United Kingdom), Novartis (Switzerland), Bristol-Myers Squibb (United States), GlaxoSmithKline plc (United Kingdom), Boehringer Ingelheim Pharmaceuticals, Inc (Germany), AstraZeneca (United Kingdom), Eli Lilly and Company (United States) and Baxter International, Inc. (United States).

On the basis of geography, the market of Poisoning Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment Type, the sub-segment i.e. Antidote will boost the Poisoning Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Agents of Poisoning, the sub-segment i.e. Sedatives will boost the Poisoning Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Incidences of Poisoning Worldwide
  • Increasing Awareness among Healthcare Providers about Antidotes

Market Trend
  • Presence of Mandatory Government Regulations

Restraints
  • Lack of Proper Reimbursement

Opportunities
  • High Potential Growth in Emerging Economies

Challenges
  • Higher Cost of Research and Development




Leading key players of poisoning treatment are focusing on strategic partnerships to improve their products & services and focusing on increasing their client base to strengthen market position.

Target Audience:
Poisoning Treatment Provider, Drug Manufacturers, Suppliers of Drugs, Healthcare Industry, Governmental Bodies and Research Firms

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Poisoning Treatment market on the basis of product [] , application [Hospital, Emergency Center and Others], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Poisoning Treatment market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Poisoning Treatment industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Poisoning Treatment market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.

Report Objectives / Segmentation Covered

By Application
  • Hospital
  • Emergency Center
  • Others
By Treatment Type
  • Antidote
  • Gastric Lavage
  • Enema
  • Hemodialysis
  • Others

By Agents of Poisoning
  • Sedatives
  • Pesticides
  • Chemicals
  • Overdose of Drugs
  • Alcohol
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidences of Poisoning Worldwide
      • 3.2.2. Increasing Awareness among Healthcare Providers about Antidotes
    • 3.3. Market Challenges
      • 3.3.1. Higher Cost of Research and Development
    • 3.4. Market Trends
      • 3.4.1. Presence of Mandatory Government Regulations
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Poisoning Treatment, by Application, Treatment Type, Agents of Poisoning and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Poisoning Treatment (Value)
      • 5.2.1. Global Poisoning Treatment by: Application (Value)
        • 5.2.1.1. Hospital
        • 5.2.1.2. Emergency Center
        • 5.2.1.3. Others
      • 5.2.2. Global Poisoning Treatment by: Treatment Type (Value)
        • 5.2.2.1. Antidote
        • 5.2.2.2. Gastric Lavage
        • 5.2.2.3. Enema
        • 5.2.2.4. Hemodialysis
        • 5.2.2.5. Others
      • 5.2.3. Global Poisoning Treatment by: Agents of Poisoning (Value)
        • 5.2.3.1. Sedatives
        • 5.2.3.2. Pesticides
        • 5.2.3.3. Chemicals
        • 5.2.3.4. Overdose of Drugs
        • 5.2.3.5. Alcohol
        • 5.2.3.6. Others
      • 5.2.4. Global Poisoning Treatment Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Poisoning Treatment (Price)
  • 6. Poisoning Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cumberland Pharmaceuticals (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BTG PLC (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bristol-Myers Squibb (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GlaxoSmithKline plc (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boehringer Ingelheim Pharmaceuticals, Inc (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AstraZeneca (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eli Lilly and Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Baxter International, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Poisoning Treatment Sale, by Application, Treatment Type, Agents of Poisoning and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Poisoning Treatment (Value)
      • 7.2.1. Global Poisoning Treatment by: Application (Value)
        • 7.2.1.1. Hospital
        • 7.2.1.2. Emergency Center
        • 7.2.1.3. Others
      • 7.2.2. Global Poisoning Treatment by: Treatment Type (Value)
        • 7.2.2.1. Antidote
        • 7.2.2.2. Gastric Lavage
        • 7.2.2.3. Enema
        • 7.2.2.4. Hemodialysis
        • 7.2.2.5. Others
      • 7.2.3. Global Poisoning Treatment by: Agents of Poisoning (Value)
        • 7.2.3.1. Sedatives
        • 7.2.3.2. Pesticides
        • 7.2.3.3. Chemicals
        • 7.2.3.4. Overdose of Drugs
        • 7.2.3.5. Alcohol
        • 7.2.3.6. Others
      • 7.2.4. Global Poisoning Treatment Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Poisoning Treatment (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Poisoning Treatment: by Application(USD Million)
  • Table 2. Poisoning Treatment Hospital , by Region USD Million (2013-2018)
  • Table 3. Poisoning Treatment Emergency Center , by Region USD Million (2013-2018)
  • Table 4. Poisoning Treatment Others , by Region USD Million (2013-2018)
  • Table 5. Poisoning Treatment: by Treatment Type(USD Million)
  • Table 6. Poisoning Treatment Antidote , by Region USD Million (2013-2018)
  • Table 7. Poisoning Treatment Gastric Lavage , by Region USD Million (2013-2018)
  • Table 8. Poisoning Treatment Enema , by Region USD Million (2013-2018)
  • Table 9. Poisoning Treatment Hemodialysis , by Region USD Million (2013-2018)
  • Table 10. Poisoning Treatment Others , by Region USD Million (2013-2018)
  • Table 11. Poisoning Treatment: by Agents of Poisoning(USD Million)
  • Table 12. Poisoning Treatment Sedatives , by Region USD Million (2013-2018)
  • Table 13. Poisoning Treatment Pesticides , by Region USD Million (2013-2018)
  • Table 14. Poisoning Treatment Chemicals , by Region USD Million (2013-2018)
  • Table 15. Poisoning Treatment Overdose of Drugs , by Region USD Million (2013-2018)
  • Table 16. Poisoning Treatment Alcohol , by Region USD Million (2013-2018)
  • Table 17. Poisoning Treatment Others , by Region USD Million (2013-2018)
  • Table 18. South America Poisoning Treatment, by Country USD Million (2013-2018)
  • Table 19. South America Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 20. South America Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 21. South America Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 22. Brazil Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 23. Brazil Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 24. Brazil Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 25. Argentina Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 26. Argentina Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 27. Argentina Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 28. Rest of South America Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 29. Rest of South America Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 30. Rest of South America Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 31. Asia Pacific Poisoning Treatment, by Country USD Million (2013-2018)
  • Table 32. Asia Pacific Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 33. Asia Pacific Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 34. Asia Pacific Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 35. China Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 36. China Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 37. China Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 38. Japan Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 39. Japan Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 40. Japan Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 41. India Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 42. India Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 43. India Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 44. South Korea Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 45. South Korea Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 46. South Korea Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 47. Taiwan Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 48. Taiwan Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 49. Taiwan Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 50. Australia Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 51. Australia Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 52. Australia Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 53. Rest of Asia-Pacific Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 55. Rest of Asia-Pacific Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 56. Europe Poisoning Treatment, by Country USD Million (2013-2018)
  • Table 57. Europe Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 58. Europe Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 59. Europe Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 60. Germany Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 61. Germany Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 62. Germany Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 63. France Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 64. France Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 65. France Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 66. Italy Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 67. Italy Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 68. Italy Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 69. United Kingdom Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 70. United Kingdom Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 71. United Kingdom Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 72. Netherlands Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 73. Netherlands Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 74. Netherlands Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 75. Rest of Europe Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 76. Rest of Europe Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 77. Rest of Europe Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 78. MEA Poisoning Treatment, by Country USD Million (2013-2018)
  • Table 79. MEA Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 80. MEA Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 81. MEA Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 82. Middle East Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 83. Middle East Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 84. Middle East Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 85. Africa Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 86. Africa Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 87. Africa Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 88. North America Poisoning Treatment, by Country USD Million (2013-2018)
  • Table 89. North America Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 90. North America Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 91. North America Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 92. United States Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 93. United States Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 94. United States Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 95. Canada Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 96. Canada Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 97. Canada Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 98. Mexico Poisoning Treatment, by Application USD Million (2013-2018)
  • Table 99. Mexico Poisoning Treatment, by Treatment Type USD Million (2013-2018)
  • Table 100. Mexico Poisoning Treatment, by Agents of Poisoning USD Million (2013-2018)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Poisoning Treatment: by Application(USD Million)
  • Table 112. Poisoning Treatment Hospital , by Region USD Million (2019-2024)
  • Table 113. Poisoning Treatment Emergency Center , by Region USD Million (2019-2024)
  • Table 114. Poisoning Treatment Others , by Region USD Million (2019-2024)
  • Table 115. Poisoning Treatment: by Treatment Type(USD Million)
  • Table 116. Poisoning Treatment Antidote , by Region USD Million (2019-2024)
  • Table 117. Poisoning Treatment Gastric Lavage , by Region USD Million (2019-2024)
  • Table 118. Poisoning Treatment Enema , by Region USD Million (2019-2024)
  • Table 119. Poisoning Treatment Hemodialysis , by Region USD Million (2019-2024)
  • Table 120. Poisoning Treatment Others , by Region USD Million (2019-2024)
  • Table 121. Poisoning Treatment: by Agents of Poisoning(USD Million)
  • Table 122. Poisoning Treatment Sedatives , by Region USD Million (2019-2024)
  • Table 123. Poisoning Treatment Pesticides , by Region USD Million (2019-2024)
  • Table 124. Poisoning Treatment Chemicals , by Region USD Million (2019-2024)
  • Table 125. Poisoning Treatment Overdose of Drugs , by Region USD Million (2019-2024)
  • Table 126. Poisoning Treatment Alcohol , by Region USD Million (2019-2024)
  • Table 127. Poisoning Treatment Others , by Region USD Million (2019-2024)
  • Table 128. South America Poisoning Treatment, by Country USD Million (2019-2024)
  • Table 129. South America Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 130. South America Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 131. South America Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 132. Brazil Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 133. Brazil Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 134. Brazil Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 135. Argentina Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 136. Argentina Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 137. Argentina Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 138. Rest of South America Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 139. Rest of South America Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 140. Rest of South America Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 141. Asia Pacific Poisoning Treatment, by Country USD Million (2019-2024)
  • Table 142. Asia Pacific Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 143. Asia Pacific Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 144. Asia Pacific Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 145. China Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 146. China Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 147. China Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 148. Japan Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 149. Japan Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 150. Japan Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 151. India Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 152. India Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 153. India Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 154. South Korea Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 155. South Korea Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 156. South Korea Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 157. Taiwan Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 158. Taiwan Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 159. Taiwan Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 160. Australia Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 161. Australia Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 162. Australia Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 163. Rest of Asia-Pacific Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 164. Rest of Asia-Pacific Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 165. Rest of Asia-Pacific Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 166. Europe Poisoning Treatment, by Country USD Million (2019-2024)
  • Table 167. Europe Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 168. Europe Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 169. Europe Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 170. Germany Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 171. Germany Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 172. Germany Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 173. France Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 174. France Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 175. France Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 176. Italy Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 177. Italy Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 178. Italy Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 179. United Kingdom Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 180. United Kingdom Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 181. United Kingdom Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 182. Netherlands Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 183. Netherlands Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 184. Netherlands Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 185. Rest of Europe Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 186. Rest of Europe Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 187. Rest of Europe Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 188. MEA Poisoning Treatment, by Country USD Million (2019-2024)
  • Table 189. MEA Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 190. MEA Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 191. MEA Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 192. Middle East Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 193. Middle East Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 194. Middle East Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 195. Africa Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 196. Africa Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 197. Africa Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 198. North America Poisoning Treatment, by Country USD Million (2019-2024)
  • Table 199. North America Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 200. North America Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 201. North America Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 202. United States Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 203. United States Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 204. United States Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 205. Canada Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 206. Canada Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 207. Canada Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 208. Mexico Poisoning Treatment, by Application USD Million (2019-2024)
  • Table 209. Mexico Poisoning Treatment, by Treatment Type USD Million (2019-2024)
  • Table 210. Mexico Poisoning Treatment, by Agents of Poisoning USD Million (2019-2024)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Poisoning Treatment: by Application USD Million (2013-2018)
  • Figure 5. Global Poisoning Treatment: by Treatment Type USD Million (2013-2018)
  • Figure 6. Global Poisoning Treatment: by Agents of Poisoning USD Million (2013-2018)
  • Figure 7. South America Poisoning Treatment Share (%), by Country
  • Figure 8. Asia Pacific Poisoning Treatment Share (%), by Country
  • Figure 9. Europe Poisoning Treatment Share (%), by Country
  • Figure 10. MEA Poisoning Treatment Share (%), by Country
  • Figure 11. North America Poisoning Treatment Share (%), by Country
  • Figure 12. Global Poisoning Treatment share by Players 2018 (%)
  • Figure 13. Global Poisoning Treatment share by Players (Top 3) 2018(%)
  • Figure 14. Global Poisoning Treatment share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Cumberland Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 17. Cumberland Pharmaceuticals (United States) Revenue: by Geography 2018
  • Figure 18. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pfizer (United States) Revenue: by Geography 2018
  • Figure 20. BTG PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. BTG PLC (United Kingdom) Revenue: by Geography 2018
  • Figure 22. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Novartis (Switzerland) Revenue: by Geography 2018
  • Figure 24. Bristol-Myers Squibb (United States) Revenue, Net Income and Gross profit
  • Figure 25. Bristol-Myers Squibb (United States) Revenue: by Geography 2018
  • Figure 26. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2018
  • Figure 28. Boehringer Ingelheim Pharmaceuticals, Inc (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Boehringer Ingelheim Pharmaceuticals, Inc (Germany) Revenue: by Geography 2018
  • Figure 30. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. AstraZeneca (United Kingdom) Revenue: by Geography 2018
  • Figure 32. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 33. Eli Lilly and Company (United States) Revenue: by Geography 2018
  • Figure 34. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Baxter International, Inc. (United States) Revenue: by Geography 2018
  • Figure 36. Global Poisoning Treatment: by Application USD Million (2019-2024)
  • Figure 37. Global Poisoning Treatment: by Treatment Type USD Million (2019-2024)
  • Figure 38. Global Poisoning Treatment: by Agents of Poisoning USD Million (2019-2024)
  • Figure 39. South America Poisoning Treatment Share (%), by Country
  • Figure 40. Asia Pacific Poisoning Treatment Share (%), by Country
  • Figure 41. Europe Poisoning Treatment Share (%), by Country
  • Figure 42. MEA Poisoning Treatment Share (%), by Country
  • Figure 43. North America Poisoning Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cumberland Pharmaceuticals (United States)
  • Pfizer (United States)
  • BTG PLC (United Kingdom)
  • Novartis (Switzerland)
  • Bristol-Myers Squibb (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Boehringer Ingelheim Pharmaceuticals, Inc (Germany)
  • AstraZeneca (United Kingdom)
  • Eli Lilly and Company (United States)
  • Baxter International, Inc. (United States)
Select User Access Type

Key Highlights of Report


Oct 2019 217 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Poisoning Treatment Market Quantitative research analysis
Global Poisoning Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Poisoning Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Ambulatory Surgical Centers (ASCs) Comprehensive Study by Type (Clinical IT Solutions, Non-Clinical Healthcare IT Solutions, HCIT Outsourcing Services), Specialty (Single Specialty, Multi-Specialty),...
$ 3750
Pain Management Comprehensive Study by Type (Pharmaceuticals, Devices), Application (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstet...
$ 4000
Laboratory Fume Hood Comprehensive Study by Type (Full Exhaust Fume Hood, Makeup Air Fume Hood, VAV (Variable Air Volume) Fume Hood), Application (Undergraduate Teaching Labs, Industrial and Biomedic...
$ 3350
Ultrasonic Sound Body Composition Comprehensive Study by Type (Dual-Energy X-Ray Absorptiometry (DXA), Air Displacement Plethysmography, Hydrostatic Weighing (HWD), Bio-Impedance Analyzers, Others), ...
$ 3750
Slimming Weight Management Comprehensive Study by Type (Weight Loss Diet, Fitness Equipment, Surgical and Equipment, Weight Loss Programs), Application (Fitness Centers, Gyms, Health Clubs, Others), ...
$ 3450
Adiponectin Testing Comprehensive Study by Type (ELISA Testing, Enzyme Immunoassay Testing, Others), Application (Hospital, Specialty Clinic, Diagnostics Laboratory, Others), Disease Type (Non-Alcoho...
$ 3750